News
-
-
-
-
PRESS RELEASE
Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year
Catheter Precision, Inc. announces major expansion in business development team to drive growth and market penetration in cardiac electrophysiology. Hiring experienced industry veterans and technical experts -
-
PRESS RELEASE
Catheter Precision, Inc. (NYSE American:VTAK) Releases Operational Performance Report, Q4 and Annual 2023 Financials for Year Ending December 31, 2023
Catheter Precision, Inc. releases Q4 and Annual Financials for 2023, showcasing revenue growth. Achievements in clinical data and IP advancements noted -
-
-
-
PRESS RELEASE
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First use of VIVO in Qatar
Catheter Precision, Inc. announces the groundbreaking use of VIVO in electrophysiology procedures at Hamad Medical Corporation Heart Hospital in Qatar, with focus on streamlining workflow and expanding in the Middle East